MediciNova announces exploratory interim clinical outcomes data from clinical trial
MediciNova announced exploratory interim data from MediciNova's ongoing clinical trial of MN-166 (ibudilast) in amyotrophic lateral sclerosis. The exploratory interim analysis compared clinical outcomes for subjects at two time points. December 09, 2016